After the FDA spent years rejecting over flavored vape products, Trump reportedly pressed his FDA chief to allow mango and blueberry flavors
Fortune
Last updated: May 7, 2026
The Food and Drug Administration (FDA) has authorized the sale of mango and blueberry-flavored products from an L.A.-based company. This decision represents a significant policy shift, diverging from previous Biden-era regulations concerning flavored tobacco and nicotine products.
- The FDA's authorization allows for the marketing of these specific fruit-flavored products, a move that contrasts with the more restrictive approach previously implemented. The previous policies aimed to curb youth appeal and reduce overall tobacco use, particularly by limiting access to flavored options.
- This new authorization suggests a potential re-evaluation of the FDA's strategy regarding flavored nicotine products. The specific details of the company and the exact nature of the products (e.g., e-cigarettes, traditional tobacco) are not fully elaborated in the provided text, but the emphasis is on the flavored aspect.
- The decision to approve these flavors signifies a notable change in the FDA's regulatory stance. It implies a possible move towards allowing a broader range of flavored products, which could have implications for public health discussions and industry practices.
- The pivot indicates a new direction for the FDA under its current leadership, moving away from the stringent limitations previously in place.
